Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 8/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.53 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9973716 | 0.91 | CYP11B2 (0.53) | CYP11B2CYP11B1CYP19A1CYP17A1MAPT | |
| SCHEMBL9973740 | 0.89 | CYP19A1 (0.50) | CYP11B2CYP11B1CYP19A1CYP17A1MAPT | |
| SCHEMBL9973737 | 0.87 | CYP2A6 (0.44) | CYP11B2CYP11B1CYP19A1CYP17A1ALDH1A1 | |
| SCHEMBL29291487 | 0.87 | CYP11B2 (0.56) | CYP11B2CYP11B1CYP19A1CYP17A1MAPT | |
| SCHEMBL9973728 | 0.87 | CYP2A6 (0.44) | CYP11B2CYP11B1CYP19A1CYP17A1ALDH1A1 | |
| SCHEMBL9973681 | 0.86 | CYP19A1 (0.49) | CYP11B2CYP11B1CYP19A1CYP17A1MAPT | |
| SCHEMBL18560796 | 0.84 | TUBB4A (0.37) | CYP11B2CYP11B1ALDH1A1NPC1RAB9A | |
| SCHEMBL17253860 | 0.84 | KDM4E (0.38) | CYP11B2CYP11B1CYP19A1CYP17A1ALDH1A1 | |
| SCHEMBL9973775 | 0.83 | CYP19A1 (0.42) | CYP11B2CYP11B1CYP19A1CYP2A6CYP3A4 | |
| SCHEMBL15369932 | 0.82 | CYP19A1 (0.46) | CYP11B2CYP11B1CYP19A1CYP17A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLC25A11, ELAVL1, SLC26A3 | CYP11B2 1338/4885CYP11B1 1482/4885CYP19A1 3499/4885 |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SLC25A11, ELAVL1, SLC26A3 | CYP11B2 1338/4885CYP11B1 1482/4885CYP19A1 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.